跳至主要内容
临床试验/CTRI/2022/11/047026
CTRI/2022/11/047026尚未招募未知

â?? EFFICACY OF TRANEXAMIC ACID IN DECREASING BLOOD LOSS DURING AND AFTER CESAREAN SECTIO

Dr Krishna Memakiya0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Age > 18 year
  • 2)Cesarean delivery, either before or during labor
  • 3)Gestational age >= 34 weeks
  • 4)Prenatal hemoglobin level in the week before the cesarean > 9 gm%
  • 5)Signed informed consent

排除标准

  • 1)History of venous (deep vein thrombosis and/or pulmonary embolism) or arterial (angina pectoris,myocardial infarction, or stroke) thrombosis
  • 2) History of epilepsy or seizure
  • 3)Any known active cardiovascular, renal or liver disorders
  • 4) Autoimmune disease
  • 5) Sickle cell disease
  • 6) Severe hemorrhagic disease
  • 7) Abnormally invasive placenta (placenta accrete /increta/percreta)
  • 8) Abruptio placentae and placenta previa
  • 9) Eclampsia or HELLP (Hemolysis Elevated Liver Low Platelet) syndrome
  • 10) In utero fetal death
  • 11)Administration of low-molecular-weight heparin or antiplatelet agents in the week before delivery
  • 12) Known hypersensitivity to tranexamic acid or concentrated hydrochloric acid
  • 13) Cesarean delivery for the second twin or second/ third triplet(s) after vaginal birth of the first twin

研究者

发起方
Dr Krishna Memakiya

相似试验